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Inhibition of the Kv4 (Shal) Family of Transient K+ Currents by 
Arachidonic Acid 
Alvaro Villarroel and Thomas L. Schwarz 
Department of Molecular and Cellular Physiology, Beckman Center, Stanford University, Stanford, California 94305 
We have found that transient A-type currents expressed in 
Xenopus oocytes from members of the Kv4 family are sup- 
pressed by arachidonic acid. Currents from members of the 
Kvl, Kv2, and Kv3 families showed little or no inhibition by fatty 
acids in ‘this expression system, although Shaker currents 
showed a modest increase in peak amplitude. The inhibition of 
Kv4 channels was not prevented by cycle-oxygenase, lipoxy- 
genase, or cytochrome P-450 inhibitors and was mimicked by 
5,8,11,14-eicosatetraynoic acid, an arachidonic acid analog 
that is not metabolized by these pathways. Other unsaturated 
cis fatty acids with more than two double bonds produced a 
similar effect. In inside-out macropatches, the current was re- 
versibly reduced ~50% by 2 PM arachidonic acid, and the 
inhibition developed in <40 sec. These results suggest that, at 
concentrations that are likely to be physiologically relevant, 
arachidonic acid interacts directly with the channel or with a 
closely associated component. Preliminary mutagenesis of 
Kv4.2 channels indicates that the N terminal is not required for 
arachidonic acid action but that the S4-S5 loop may influence 
the effect. 
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Arachidonic acid can regulate neuronal excitability and synaptic 
transmission (Palmer et al., 1980; Vacher et al., 1989; Fraser et al., 
1993). Ion channels, including Na+ (Linden and Routtenberg, 
1989), Ca2+ (Keyser and Alger, 1990), Cll (Anderson and Welsh, 
1990; Hwang et al., 1990), K+ (see below), and agonist-operated 
channels (Schwartz et al., 1988; Miller et al., 1992; Vijayaraghavan 
et al., 1995) are each targets of arachidonic acid action (for 
review, see Bevan and Wood, 1987; Clapham, 1990; Piomelli and 
Greengard, 1990; Ordway et al., 1991). These effects on channels 
may be parts of physiological pathways for modulation. In re- 
sponse to transmitters and hormones, arachidonic acid can be 
released from membranes by the activation of phospholipase A, 
by G-proteins or elevated intracellular Ca2+ (Chang et al., 1987; 
Burch, 1989) (for review, see Axelrod et al., 1988; Kim et al., 
1989). Arachidonic acid can also be produced by the sequential 
participation of phospholipases C and D or diacylglycerol lipase 
(Bell et al., 1979) (for review, see Loffelholz, 1989). There is also 
an increase in free arachidonic acid concentration under patho- 
logical conditions such as ischemia, epilepsy, or stroke (Shimizu 
and Wolfe, 1990). Once produced within a cell, arachidonic acid 
can activate additional second-messenger pathways [e.g., Ca*+ 
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(Knepel et al., 1988) and protein kinase C (PKC) (McPhail et al., 
1984)] and can be transformed via several routes (cyclo- 
oxygenase, lipoxygenase, and epoxygenase) into additional active 
metabolites (for review, see Needleman et al., 1986). 
Modulation of Kt channels by arachidonic acid is widespread 
and diverse. The enhancement of the S-current in Aplysiu sensory 
neurons by the peptide FMRF-amide (Piomelli et al., 1987), the 
enhancement of the M-current in rat CA1 hippocampal neurons 
by somatostatin (Schweitzer et al., 1990), and the modulation of 
the inward rectifier in cardiac myocytes by angiotensin (Kurachi et 
al., 1989a,b) or platelet-activating factor (Nakajima et al., 1991) 
are mediated by lipoxygenase metabolites of arachidonic acid. 
Metabolites of the epoxygenase pathway induce the opening of 
K+ channels in epithelial cells (Hu and Kim, 1993). The modu- 
lation of ATP-sensitive K’ channels in insulinoma cells by ara- 
chidonic acid likely is mediated by PKC (Miiller et al., 1992); 
additionally, arachidonic acid itself causes the opening of K+ 
channels in smooth muscle (Ordway et al., 1989) cardiac myo- 
cytes (Kim and Clapham, 1989) and cultured mesencephalic and 
hypothalamic neurons (Kim et al., 1995) and activates large- 
conductance Ca’+-activated K+ channels in vascular smooth mus- 
cle (Kirber et al., 1992). Arachidonic acid also potently suppresses 
the A-current in sympathetic neurons (Blair and Suprenant, 1993; 
Villarroel, 1993). 
Little is known, however, about the molecular basis of arachi- 
donic acid action on ion channels, although many of them have 
been cloned and expressed. Most of the cloned voltage-dependent 
K+ channels appear to be encoded by four gene families. These 
families can be identified by their Drosophila gene homolog 
(Shaker, Shah, Shaw, and Shal) or by an alternative nomenclature 
(Kvl, Kv2, Kv3, and Kv4) (Wei et al., 1990). This classification has 
physiological consequences because different subunits of the same 
family can combine to form a functional tetrameric channel in 
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oocytes, whereas members of different families do not (Covarru- 
bias et al., 1991; Salkoff et al., 1992). Excitable cells may take 
advantage of the great diversity of Kt channels by selectively 
modulating the properties of some channels and not others in 
response to stimuli. 
We have studied the effects of arachidonic acid on voltage- 
dependent K+ channels expressed in Xenopus oocytes. We have 
screened several channels and have found that the members of the 
Kv4 family are inhibited by arachidonic acid. The arachidonic acid 
effect appears to be direct, and the modulation does not involve 
changes in the voltage dependence of inactivation or in the rate of 
activation or inactivation. These are also characteristics of the 
inhibition by muscarine and arachidonic acid of the A-current in 
sympathetic neurons (Blair and Suprenant, 1993; Villarroel, 1993, 
1994). Thus, the effect we observe in oocytes on Kv4-family 
channels may underlie the muscarinic regulation of IA in sympa- 
thetic neurons as well as inhibition of IA in other cells. In addition, 
the modulation observed in oocytes can provide a system for the 
detailed study of fatty-acid effects on an ion channel. 
MATERIALS AND METHODS 
In vitro transcription and oocyte injection. cDNAs were linearized and 
RNA was synthesized in vitro with the following enzymes: fly Shaker 
(EcoRIIT3) (Timpe et al., 1988) rat Kvl.1 [RCKl] (KpnIiT3) (Swanson 
et al., 1990), bovine Kv1.2 [BEKS] (XhoIIT3) (H.-Y. Mi, unpublished 
observations), rat Kv1.3 [Kv3] (HindIII/T7) (Swanson et al., 1990), hu- 
man Kv1.4 IRCK4] (EcoRIISP6) (PO et al., 1992), rat Kv1.5 [Kvl] 
(NotIjT7) (Swanson-et al., 1990) rat Kv2.1 [DRKl] (SacIiT3) (Frech et 
al., 1989), mouse Kv2.1 [&hub] (SacII/T3) (Pak et al., 1991b), mouse 
Kv4.1 (SacI/TS) (Pak et al., 1991a), rat Kv4.2 (NotIiT7) (Baldwin et al., 
1991), fly Shal2 (SacII/T3) (Wei et al., 1990) rat Kv3.1 [NGKl] (NotIiT7) 
fHartmann et al.. 1991). human Kv3.4 fSalIIT3) (Rudv et al.. 1991). Rat 
Kv4.2 was subcloned inthe pMT2 vector (Swick et al.: 1992)for nuclear 
injection. This method was preferred for Kv4.2 because comparable levels 
of expression (peak currents of 4-9 FA at +40 mV, from a holding 
potential of -90 mV) were difficult to obtain even with very high 
concentrations of cRNA. 
Stage V or VI oocytes were defolliculated enzymatically with collage- 
nase 11.5 mgiml in Ca*+-free OR2. made with (in mM): NaCl 82.5. KC1 
2.5, MgCI, 7, HEPES 5, pH 7.6]‘for 2 hr at room temperature: The 
oocytes were injected with 50 nl of cRNA or with lo-30 nl of cDNA (10 
@ml) for nuclear injection of Kv4.2. Oocytes were kept in ND96 buffer 
[(in mM) NaCl 96, KC1 2, CaCI, 1.8, MgCI, 1, HEPES 5, pH 7.61 at 18°C 
and used for recording l-4 d after injection. All recordings were done at 
room temperature (-22°C). 
Electrophysiology. Whole-cell currents were recorded in oocytes under 
two-electrode voltage clamp, by using a virtual-ground Warner oocyte 
clamp OC-725A amplifier (180 V compliance; Warner Instruments, 
Hamden, CT). To increase the clamping performance, the capacitor on 
the DC gain was substituted by a series of 10 selectable capacitors (from 
1 FF to 10 pF). We were able to clamp wild-type Shaker currents of 70 PA 
evoked from -80 mV during a step to +60 mV in CO.5 msec with the 
capacitor set to the lowest value. Most experiments were done with the 10 
pF capacitor setting. The electrodes were filled with 3 M KC1 and had 
resistances of 0.3-l MIL. Linear capacitative and leakage currents were 
subtracted on-line by a P/4 or P/5 pulse protocol, except where indicated. 
The oocytes were bathed in “Xen&s saline” made with (in mM): NaCl 
100. KC1 2.5. M&l, 1. MnCl, 2, HEPES 5. nH-adiusted to 7.2 with 
NaGH. Mn” was included in the solution to block C@ currents and to 
prevent the activation of the endogenous Ca’+-activated Cl- current. 
The presence of 2 mM Mn*+ instead of Ca*+ caused a shift in the 
half-inactivation voltage on the inactivating currents tested. The shift was 
6.0 + 0.3 mV (n = 5) for Kv1.4 currents (from -52.1 + 3.0 to -46.1 ? 
3.1 mV), 12.2 mV (n = 1) for Kv3.2 currents (from - 10.3 to 1.8 mV), and 
14.7 2 1.0 mV (n = 7) for Kv4.2 currents (from -70.9 +- 2.2 to -56.2 + 
2.1 mV). Similar shifts in the voltage dependence of inactivating Kt 
channels have been described previously (Mayer and Sugiyama, 1988; 
Agus et al., 1991). The currents were filtered at 2500 Hz with an &pole 
Bessel filter (Frequency Devices 902, Haverhill, MA). 
The vitellin layer was stripped for patch recording using a hypertonic 
solution composed of 0.1 gm/ml sucrose plus (in mM): NaCl 100, KC1 
32.5, MgCl, 1, MnCI, 0.5, HEPES 5, pH 7.2. The oocytes were bathed in 
“patch-formation saline” made of (in mM): KC1 100, MgCl, 0.5, MnCI, 
0.5, HEPES 5, pH 7.2 (adjusted with NaGH). The electrode was made 
from micropipettes (Drumond, Broomall, PA). fire-polished. and filled 
with Xenopus-saline;‘the resulting resistances were on the order of 4-5 
MR. After seal formation, the electrode was pushed into the oocyte to 
establish the inside-out configuration; then it was retracted rapidly and 
transferred to “inside-out saline,” which had a composition similar to 
patch formation saline, except that it contained 1 mM EGTA and no 
MnCI,. The currents were recorded with an Axopatch-1C amplifier 
(Axon Instruments, Foster City, CA) and filtered at 500 Hz with the 
incorporated 3-pole Bessel filter. The external salines were perfused 
continuously at 2.5 mlimin in a small chamber of 1.7 X 1.7 mm2 cross- 
section. All drugs were stored as a 100 mM stock solution in dimethyl- 
sulfoxide (DMSO) in sealed amber vials under N, at -80°C. DMSO was 
dehydrated with Sigma molecular sieves (3 8, nominal pore diameter; St. 
Louis, MO). For recordings, the stocks were diluted into saline containing 
0.1% DMSO. Thus, when the final concentration of a drug was 50 PM, the 
DMSO concentration was 0.15%. DMSO at concentrations as high as 
0.25% did not produce anv significant effect on Shaker or rat Kv4.2 
currents. Arachihonic acid and-5,8,11,14-eicosatetraynoic acid (ETYA) 
did not have an appreciable effect on uninjected oocytes or on the holding 
and leakage currents of oocytes expressing Kt channels. 
Drugs. Arachidonic acid was from Calbiochem (La Jolla, CA); 5,8,11- 
eicosatriynoic acid (ETI) was from Cayman Chemical (Ann Arbor, MI); 
ETYA, 8,11-eicosadiynoic acid (EDYA), linolenic acid, y-linolenic acid, 
caffeic acid, methoxsalen, proadifem (SKF-525A), and esculetin were 
from BioMol Research Labs (Plymouth Meeting, PA). All other drugs 
were from Sigma. 
Mutagenesis. The amino acids at position 3-28 of Kv4.2 were deleted by 
PCR-based mutagenesis. The 5’-end primer was a 27 mer in which the 
sequences encoding amino acids 29-32 were preceded by a sequence that 
encoded amino acids l-3 and introduced an NcoI site at the position of 
the start methionine (C GGG CCC ATG GCA GCT CCC CCA AGG 
CA). The 3’-end oligo was complementary to a region on the Sl-S2 
extracellular loop. The amplified product contained an additional NcoI 
site found at position T182 in Kv4.2. The Kv4.2 clone contained an NcoI 
site at the start methionine. Both Kv4.2 and the PCR product were 
digested with NcoI, gel-purified, and ligated together; clones with the 
proper orientation were selected. The deletion was found to contain an 
unintended R -+ P mutation at position 32; however, because the action 
of arachidonic acid was preserved in these deleted channels (see below), 
this additional mutation did not pose a problem for the interpretation of 
the results. 
The Kv4.2 chimera containing the S4-S5 loop from Shaker was made 
bv using a multisten PCR protocol that exchanged the seauence LRILG- 
GYTLI?wE from Kvi.2 with LQILGRYFLKASMRE from Shaker 
(nonconserved amino acids are underlined). The first PCR amplified a 
segment of a Shaker construct that previously had introduced silent StuI 
site at position G379 (a gift from Dr. R. Aldrich, Stanford University). 
There is a StuI site at the equivalent position in Kv4.2 (G309). The 
3’-primer (primer Bl) was a hybrid between Shaker and Kv4.2 sequences 
(GAG CTC CCG CAT TGA AGC ‘MT CAG AGT TCG TCC), and the 
5’-primer (primer Al) flanked the StuI site. Primer Bl introduced a 
Hind111 site that was used for the screening of positive clones. The second 
PCR amplified the adjacent region of Kv4.2. The 5’-primer for the second 
PCR (primer A2: GCT TCA ATG CGG GAG CTC GGC TIC TTG 
CTC TIT TCC) partially overlapped primer Bl, and the 3’-primer 
(primer B2) flanked the KpnI site of Kv4.2. The third PCR was performed 
by mixing %oo of the product of PCR 1 and 2, and amplifying with primers 
Al and B2. The product was subcloned between the StuI and !@I sites 
of Kv4.2. The sequence of this region was verified. 
The Shaker chimera containing the S4-S5 loop from Kv4 was gener- 
ously provided by Drs. C. Smith-Maxwell and R. Aldrich, Stanford 
University. 
RESULTS 
Kv4 currents are selectively inhibited when expressed 
in Xenopus oocytes 
To establish a system for studying the effects of arachidonic acid 
on a molecularly defined K+ channel, we expressed 12 channels in 
Xenopus oocytes, including representatives of each of the four 
main families of voltage-dependent Kt channels. Figure 1 shows 
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Figure 1. Arachidonic acid selectively inhibits Kv4-family channels 
expressed in Xenopus oocytes. Currents from nine cloned K+ channels 
expressed in Xenopus oocytes were examined in standard solution (solid 
lines) and in the presence of 25 PM arachidonic acid (dotted lines and 
arrows). The currents were evoked by stepping the membrane potential 
to +40 mV from a holding potential of -80 mV, except for Kv1.4, 
which was held at - 100 mV. The horizontal calibration bar is 30 msec 
and the vertical bar (from top to bottom, left to right) is (in PA) 8.1,7.7, 
5.7, 2.5, 8.0, 4.2, 0.6, 1.2, and 0.8. The traces were leak-subtracted 
on-line using a P/4 or P/5 protocol. 
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the effect of 25 PM arachidonic acid on several of these. The most 
dramatic effect observed was the 57.8 + 1.7% (n = 5) (mean ? 
SD, n = number of experiments) reduction of rat Kv4.2 current, 
which encodes an A-type transient K’ current. A similar potent 
reduction was observed with other members of this family: mouse 
Kv4.1 and tly Shal. In contrast, the peak Shaker current was 
enhanced by 20.5 5 4.1% (n = 4; see also Fig. 30). Only minor 
effects were observed in the other channels tested (bovine Kv1.2, 
rat Kv1.3, human Kv1.4, rat Kv1.5, rat Kv2.1, mouse Kv2.1, rat 
Kv3.1, and rat Kv3.4). 
The response to arachidonic acid was studied in more detail in 
rat Kv4.2, because the effect was robust. In addition, a similar 
reduction had been observed for the A-current in sympathetic 
neurons in response to muscarine (which is known to mobilize 
arachidonic acid) and to externally applied arachidonic acid (Blair 
and Suprenant, 1993; Villarroel, 1993, 1994). 
The reduction in the current induced by arachidonic acid de- 
veloped slowly, reaching a near-steady-state value in -5 min (Fig. 
2). After arachidonic acid washout, the current recovered very 
slowly, probably because of the difficulty of removing arachidonic 
acid from the interior of the oocyte. To accelerate the recovery, 
bovine serum albumin (BSA), which binds fatty acids, was added 
to the bathing solution, and the current recovered to -90% of the 
control level in 5 min. BSA by itself occasionally caused a very 
slight increase in the peak current (no more than 5%). 
In sympathetic neurons, the arachidonic acid-mediated IA in- 
hibition is mimicked by the nonhydrolyzable arachidonic acid 
analog ETYA. This is true for the reduction of Kv4.2 current in 
oocytes as well (10 PM ETYA, Fig. 3A). To compare the effects of 
Figure 2. Time course of Kv4.2 inhibition by arachidonic acid.A, Peak 
current evoked from a holding potential of -90 mV during a step to 
+40 mV. The times of application of B&4 (0.5 mg/ml) and arachidonic 
acid (AA) are indicated by the bars. Because of its ability to bind fatty 
acids, BSA was used to hasten the washout of arachidonic acid. BSA 
alone caused a very slight augmentation of the current (compare d and 
e). B, Representative traces of Kv4.2 currents taken at time points a-e 
indicated in A. 
the two fatty acids (and other fatty acids used in this study), 
cumulative dose-response curves were made by bath-applying a 
series of increasing concentrations of a drug, doubling the drug 
concentration every 3 min. This protocol was selected as a way to 
compare a full range of concentrations on individual oocytes, 
while circumventing the lengthy times required for the washout of 
fatty acids and the baseline changes in the oocytes caused by 
protracted recordings. Although 3 min was not always sufficient to 
reach a complete steady state of blockade (Fig. 24), extending the 
application to 9 min caused only a minor shift in the dose- 
response curves (data not shown). 
Figure 3C (open circles) shows a cumulative dose response for 
arachidonic acid. The maximal reduction obtained with this cu- 
mulative protocol was estimated to be 67.9 5 2.0% (n = 5) and 
the IC,, was -8 PM. Under these assay conditions, ETYA was 
more potent than arachidonic acid (Fig. 3C, filled circles). The 
maximal reduction was 73.0 -C 3.9% (n = 9) and the IC5,, was -2 
FM. Fly Shal and mouse Kv4.1 also were potently suppressed by 
Villarroel and Schwarz l Arachidonic Acid Inhibition of Kv4 Family K+ Currents J. Neurosci., April 15, 1996, 76(8):2522-2531 2525 
1 
A 2. 09 
5ms O 
Shaker 
T 
Concentration (PM) Concentration (PM) 
Figure 3. ETYA mimics the effects of arachidonic acid on Kv4.2 but 
not on Shaker. A, Effect of 10 pM ETYA on Kv4.2 (dot& line and 
arrows). The current was evoked by a voltage step from -90 to +40 
mV. The traces were not leak-subtracted. The small increase in holding 
current was not related to the application of ETYA. B, Effect of 10 PM 
ETYA on Shaker (dotted line). The current was evoked by a voltage 
step from -80 to +40 mV. The traces were not leak-subtracted. C, 
Cumulative dose-response relationship of Kv4.2 to ETYA (‘j&d cir- 
cles; IZ = 9) and arachidonic acid (open circles; IZ = 5). The cumulative 
dose-response relationship was determined by exposing the oocytes to 
a series of bath solutions such that the drug concentration was doubled 
every 3 min, and the amplitude of the Kv4.2 current was monitored 
with repeated voltage steps. Generally similar dose-response curves 
(data not shown) were obtained from 9 min incubations, which allowed 
the fatty acid effects to come more fully to equilibrium. Bars represent 
the SEM. D, Cumulative dose response of Shaker to ETYA (filled 
circles; n = 3) and arachidonic acid (open circles; n = 4). 
ETYA (data not shown). In contrast, ETYA did not mimic the 
effect of arachidonic acid on Shaker currents, causing little or no 
enhancement (Fig. 3B,D). 
The marked effect of arachidonic acid and ETYA on Kv4.2 
currents in oocytes allowed us to investigate the mechanism by 
which a fatty acid can alter channel function. Analysis of voltage- 
clamped currents in the presence and absence of these agents 
revealed that neither arachidonic acid nor ETYA shifted the 
voltage dependence of inactivation (Fig. 4A). The effect on the 
voltage dependence of activation could not be examined accu- 
rately because a maximum conductance was not reached. In 
addition, neither arachidonic acid nor ETYA substantially 
changed the activation or inactivation kinetics as shown in Figure 
4C, in which the current trace in the presence of ETYA (dotted 
line) has been scaled to the peak of the control current (solid line). 
In this context, the inhibition in oocytes is similar to the effect of 
arachidonic acid on 1, in sympathetic neurons (Villarroel, 1993). 
In contrast, the arachidonic acid-mediated enhancement of 
Shaker current was accompanied by a -6.3 2 2.7 mV (n = 4) shift 
in the voltage dependence of inactivation (Fig. 4B), and by an 
acceleration of the activation and inactivation kinetics (see Fig. 1). 
ETYA had little effect on the current-voltage relationship (data 
not shown) or on the activation and inactivation kinetics of Shaker 
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Figure 4. Effect of arachidonic acid and ETYA on biophysical parame- 
ters of Kv4.2 and Shaker. A, Kv4.2 inactivation (circles) and activation 
(triangles) in the presence (filled symbols) and absence (open symbols) of 
2.5 FM ETYA. Inactivation was determined by measuring the peak out- 
ward current at +40 mV after 5 set at the holding potential. After the test 
pulse, the oocyte was shifted to the next holding potential. The inactiva- 
tion curves were then scaled by normalizing them as I/I,,,,Y The activation 
curves are given as conductances (in KS). B, Shaker inactivation and 
activation in the presence (filled symbols) and absence (open symbols) of 25 
@M arachidonic acid. The protocol and normalization of the inactivation 
curves are the same as those in A. C, Comparison of the activation and 
inactivation kinetics of Kv4.2 in the presence (dotted truce) and absence 
(solid trace) of 2.5 LLM ETYA. The current in the uresence of ETYA was 
ieduced by’>50% And has been scaled for comparjson. D, Comparison of 
the kinetics of recovery from inactivation of Kv4.2 with @led circles), 
without (open circles), and after washout (open triangles) of 2.5 PM ETYA. 
Peak currents during 20 msec pulses to +40 mV have been plotted versus 
the elapsed time interval from an inactivating pulse (1 set at +40 mV). 
The membrane potential was held at -90 mV. 
currents (Fig. 3B). No major effects of ETYA were observed in 
any of the other channels tested (see above and Fig. l), except that 
the closely related Kv4.1 and fly Shal channels were inhibited in a 
manner very similar to that described for Kv4.2 (data not shown). 
The inhibition of Kv4.2 currents was accompanied by a modest, 
but significant (p < 0.05, paired t test), acceleration of the rate of 
recovery from inactivation (Fig. 40). In the presence of 2.5 PM 
ETYA, the time constant decreased from 188.3 -C 16.8 to 1.52 5 
14.4 msec at -90 mV (n = 3), and from 280.0 2 35.9 to 201.2 ? 
23.3 msec at -80 mV. Similar results were obtained with 2.5 PM 
arachidonic acid. 
The similarity of action of ETYA and arachidonic acid action 
with respect to biophysical parameters of Kv4.2 suggests that both 
fatty acids use the same mechanism to suppress the current. 
Experiments described below with injected BSA and mutant chi- 
merit channels support this hypothesis. In subsequent experi- 
ments, we often used ETYA instead of arachidonic acid because 
of its greater potency, stability, and immunity to metabolism. 
Pharmacology of Kv4.2 inhibition 
To define further the means by which these fatty acids altered 
Kv4.2 currents, we initiated a series of pharmacological experi- 
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Figure 5. Injection of BSA, but not of BAPTA, decreased ETYA inhi- 
bition. Cumulative dose response to ETYA of Kv4.2-expressing oocytes 
injected with 50 nl of saline (Open circles; n = 4) 100 mM BAPTA (qen 
triangles; n = 4) or 300 mg/ml BSA (filled circles; n = 5). Bars indicate the 
SEM. The volume of an oocyte was estimated to be 1 ~1; therefore, 
internal concentrations were -5 mM BAPTA and 160 PM BSA. 
ments. Although these compounds were applied in the bath, they 
are membrane-permeable and may be acting in the plane of the 
membrane or intracellularly. To investigate the site of action, we 
injected oocytes with BSA which, because of its ability to bind 
fatty acids, can be regarded as a fatty acid chelator (Spector et al., 
1971). In the injected cells, ETYA inhibition was partially pre- 
vented (Fig. 5, filled circles) and, therefore, it is unlikely that the 
inhibition of the current was attributable to an extracellular site of 
ETYA action. In addition, internal BSA precluded the accelera- 
tion in the rate of recovery from inhibition (data not shown). 
A hypothetical path by which internal arachidonic acid might 
act is by causing an increase in intracellular Ca’+. The A-current 
of hippocampal neurons, for example, is very sensitive to intra- 
cellular Ca2+ (Ch en and Wong, 1991) and arachidonic acid, 
presumably after reaching the cell interior, can cause an increase 
in intracellular Cazt in some cells (Oike et al., 1994). Indeed, 
because Kv4.2 is present in the dendrites and soma of hippocam- 
pal neurons (Sheng et al., 1992), it likely is a major contributor to 
this Ca2+ -sensitive A-current. To test the possibility that Ca2+ 
mediates this effect in oocytes, we injected oocytes with the potent 
Ca2+ chelator bis(2-aminophenoxy)ethane-N,N,N’,N’-tetra-acetic 
acid (BAPTA). We confirmed the efficacy of the injected BAPTA 
by monitoring the Ca2+ -activated Cl- current that is endogenous 
to the oocyte during pulses to +40 mV (in 10 mM Ca2+ and no 
added Mn2+). BAPTA injection blocked this current (data not 
shown) and, therefore, intracellular Ca2+ could be effectively 
chelated. Figure 5 shows that the cumulative dose response of 
ETYA in cells injected with BAPTA (ttiangles) was similar to the 
dose response in cells injected with buffer (Open circles); the effect 
of the fatty acid is unlikely to be mediated by Ca2+. 
Arachidonic acid that enters the oocyte could be subject to 
metabolism by the cycle-oxygenase, lipoxygenase (Hawkins and 
Brash, 1989), or cytochrome P-450 (epoxygenase) pathways, and 
one of the metabolic derivatives of arachidonic acid could be 
active on the channel. Although ETYA inhibits many of these 
enzymes and is not thought to be metabolizable, it remained 
possible that arachidonic acid was converted to a more potent 
metabolite. We attempted to block each of these pathways with 
several of the commonly used agents: 5 PM indomethacin (a 
cycle-oxygenase blocker), 50 PM nordihydroguaiaretic acid 
(NDGA), or 50 PM caffeic acid (lipoxygenase blockers), and 10 
PM proadifem or 10 PM methoxsalen (epoxygenase blockers). 
None of these inhibitors was effective in preventing the effect of 
arachidonic acid. Esculetin (50 PM), NDGA (10 PM), and clotrim- 
azole (l-10 PM) each reduced the magnitude of the current in the 
absence of arachidonic acid and, therefore, could not be used as 
blockers of arachidonic acid metabolism. Although the efficacy of 
the blockers we used is not known in the oocyte, a requisite 
metabolism of arachidonic acid appears to be unlikely. 
Another mechanism by which internal arachidonic acid might 
inhibit Kv4.2 is by activating a PKC (McPhail et al., 1984). To 
address this possibility, oocytes were incubated with the kinase 
blockers sphingosine (10 pM) and staurosporine (1 PM). No effect 
was observed on the inhibition by arachidonic acid or ETYA and, 
thus, PKC likely does not mediate this effect. 
The suppression of Kv4.2 by arachidonic acid in 
inside-out patches is fast, potent, and 
partially reversible 
The effect of arachidonic acid was studied in inside-out patches, 
which held two advantages for this investigation. First, in the 
absence of nucleotides, phosphorylation events cannot take place; 
the cytochrome P-450 pathway is not active because the cofactors 
nicotinamide-adenine dinucleotide phosphate (NADP) and re- 
duced NADP (or NADPH) are not present, and changes in 
intracellular Ca2+ cannot take place. Thus, the patch provides an 
alternative to the pharmacological investigation described above. 
In addition, the large volume of yolk in the oocyte may serve as a 
powerful sink for applied fatty acids. It can distort, therefore, the 
efficacy of bath applied arachidonic acid either by binding it or by 
metabolizing it. Inside-out patches may reveal the potency of 
arachidonic acid on the channel more accurately. 
Patch recordings were difficult because none of the channels of 
the Kv4 family expresses robustly in oocytes and the single- 
channel current of these channels is small (Baldwin et al., 1991). 
Attempts were made to obtain macropatches from the N-deleted 
mutant (noninactivating) as well as wild-type. The levels of ex- 
pression of the N-deleted mutant were higher than for the wild- 
type, and we only obtained macropatch records from the former. 
This deletion did not affect the sensitivity of the channel to 
arachidonic acid (see below). 
Figure 6A shows the effect of 4 pM arachidonic acid in an 
inside-out macropatch. The current was inhibited almost com- 
pletely in the presence of arachidonic acid (truce b) and recovered 
nearly to control levels after the drug was removed (trace c). The 
time course of the response is illustrated in Figure 6B. The 
response was much faster and more potent than in the intact 
oocyte, presumably because several barriers were removed under 
inside-out recording conditions and the internal yolk of the oocyte 
was not trapping arachidonic acid. Thus, in Figure 6B, 4 PM 
arachidonic acid acted within 20 set of application, whereas in the 
intact oocyte (see Fig. 2A) 20 pM arachidonic acid took >5 min to 
reach a steady state of block. Figure 6C compares a plot of the 
extent of inhibition at different concentrations measured 40 set 
after applying the drug. The current was suppressed completely at 
8 FM and was reduced >50% at 2 pM. After washout, the current 
recovered to 80% of control after challenging with 2 pM and to 
>65% after applying 4 or 8 PM arachidonic acid. These results 
exclude the participation of a kinase, cytochrome P-450, or Ca2+. 
The participation of a phosphatase is also very unlikely, because 
recovery would require the action of a kinase. 
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Figure 6. Inhibition of Kv4.2 by arachidonic acid in inside-out patches is 
fast, potent, and reversible. A, Currents from the N-deleted mutant were 
evoked in the inside-out configuration during a 90 msec step to +80 mV 
from a holding potential of -80 mV. The figure shows an ensemble 
average of five depolarizations (selected traces are indicated in B) in 
control conditions (a), in the presence of 4 ELM arachidonic acid (b), and 
after recovery (c). Fat-free BSA (25 j.bM) was used to help remove 
arachidonic acid (BSA alone did not have any appreciable effect on 
channel activity). L?, Plot of the total integrated current versus time. Bars 
n, b, and c indicate the records used to generate the ensemble averages in 
A and are positioned at zero current level. The bar at the top indicates the 
time of arachidonic acid application. The horizontal and vertical scale bars 
are 20 set and 250 pA . msec, respectively. C, Current amplitude as a 
percent of control at four concentrations of arachidonic acid. Vertical bars 
represent the SD. The data were obtained (from left to right) from 1,2,5, 
and 8 patches. 
The efficacy of related fatty acids does not correlate 
well with their predicted effects on membrane fluidity 
To assess the specificity of the inhibitory response, cumulative 
dose-response curves were constructed under two-electrode volt- 
age clamp for an array of structurally related fatty acids. Because 
fatty acids may cause changes in the fluidity of the membrane, we 
sought to determine whether their potency to inhibit the channel 
correlated with their predicted action on membrane fluidity. The 
extent of inhibition of different fatty acids at 25 PM is illustrated in 
Figure 7A. 
The level of unsaturation of a fatty acid and membrane fluidity 
changes are intricately related. The presence of the first cis double 
bond has the most significant effect in the physical parameters 
related to membrane fluidity (Stubbs and Smith, 1984). However, 
oleic acid, which has one cis double bond, had little effect in Kv4.2. 
This contrasts with the modulation of Cl- channels in epithelial 
cells that are blocked with oleic acid (and other cis unsaturated 
fatty acids) (Hwang et al., 1990). Fatty acids with more than two 
cis double bonds inhibited Kv4.2 significantly and had similar IC,, 
Figure 7. Pharmacology of Kv4.2 inhibition. A, The percent inhibition 
produced by different fatty acids at 25 PM is compared. The name of the 
fatty acid is followed by the number of carbon atoms, then the number of 
double bonds, and then by the nature and position of the first double bond 
(c, cis; t, truns). B, The inhibitory effects (at 5 PM) of fatty acids with triple, 
rather than double, bonds. Descriptive numbers are as above; however, 
the letter n is followed by a number indicating the position of the first 
triple bond. 
values. Linolenaidic acid (which has tram instead of cis double 
bonds) had little effect, suggesting that the cis double bonds are 
important for the effect. The carboxyl group also appears to be 
important for the inhibition, because the extent of inhibition 
produced by methyl esters of arachidonic and linolenic acids, and 
by linolenyl alcohol, was significantly lower than the reduction 
caused by the respective acids. This specificity also correlates 
poorly with changes in membrane fluidity; the methyl esters, 
alcohols, and acids are predicted to be comparable with one 
another in changing fluidity. 
The effect of fatty acid analogs with triple instead of double 
bonds was examined by constructing cumulative dose-response 
curves from 0.625 to 10 FM. These compounds are expected to 
have minimal effects on membrane fluidity, because the hydro- 
phobic carbon chain is relatively straight (the four carbon atoms 
around a triple bond are linear). The extent of inhibition pro- 
duced by 5 FM EDYA, ETI, and ETYA, which have two, three, 
and four triple bonds, respectively, is illustrated in Figure 7B. 
These analogs were more potent than arachidonic acid, which is 
an effect that is difficult to reconcile with the idea that arachidonic 
acid-mediated Kv4.2 inhibition is mediated by an alteration of 
membrane fluidity. 
Thus, in general, there is poor correlation of Kv4.2 inhibition 
and predicted effects on membrane fluidity. The efficacy of any 
individual fatty acid may have been distorted by a particular 
sensitivity of that compound to sequestration or metabolism: the 
fatty acids with triple bonds, for example, may be most potent 
because they are not metabolizable. Nevertheless, the lack of 
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correlation is so universal that a more specific interaction of fatty 
acids with the channel seems to be the more likely hypothesis. 
Arachidonic acid modulation is affected by mutations 
in the S4-S5 loop 
Because the action of arachidonic acid on Kv4.2 appears to be 
direct, we have begun a mutagenesis analysis to determine 
whether certain candidate domains of the channels are involved in 
this modulatory effect. As a starting point, we focused on the 
N-terminal portion and the S4-S5 loop of the channel for several 
reasons. (1) The acceleration of the rate of recovery from inacti- 
vation by arachidonic acid and ETYA (Fig. 40) suggested that a 
domain involved in inactivation participates. Although inactiva- 
tion has not been studied as extensively in these channels as it has 
in the Shaker channel and the Kvl family, the N-terminal domain 
has been shown to influence inactivation rates (Baldwin et al., 
1991; Pak et al., 1991a). This inactivation likely is analogous to the 
“ball and chain” model of N-inactivation in Shaker (Hoshi et al., 
1990). The S4-S5 linker may be involved in this process as a 
receptor .for the inactivation particle (Isacoff et al., 1991). (2) 
Arachidonic acid is a hydrophobic molecule, and we hypothesized 
that it interacts with hydrophobic regions of the channel. The 
N-terminal portion is very hydrophobic, and it is highly conserved 
between all of the members of the Kv4 family. (3) Current models 
of channel topology place both the N-terminal and the S4-S5 
linker on the intracellular side of the membrane; an intracellular 
action of arachidonic acid would be compatible with our obser- 
vations with injected BSA. 
To test the role of the N-terminal domain (the “ball”), a highly 
hydrophobic stretch of 26 amino acids from the N terminus 
(residues 3-28) was deleted from Kv4.2. As expected, the rate of 
inactivation in this construct was very slow (Baldwin et al., 1991; 
Pak et al., 1991a), but the effects of arachidonic acid and ETYA 
were similar to that in the wild-type channel, as determined by 
cumulative dose-response curves (data not shown). Thus the N 
terminus plays little or no role in the modulation. 
To address the role of the S4-S5 loop, which may form part of 
the receptor of the inactivation particle (Isacoff et al., 1991), this 
segment was exchanged reciprocally between A4-46-Shaker (in 
which the N-terminal domain was deleted to remove inactivation), 
and Kv4.2 channels. In Figure SA, the effect of 10 FM ETYA 
(dotted lines) is illustrated for (from left to right) Kv4.2, a chimera 
with the S4-S5 loop from Shaker in Kv4.2 background (Kv4.2/ 
S4S5,,), a chimera with the S4-S5 loop from Kv4.2 in Shaker 
background (Shaker/S4SS,,,) (a gift from Dr. Richard Aldrich), 
and A4-46-Shaker. Specifically, the exchanged sequences were 
(with nonconserved amino acids underlined): LRILGGYTLK- 
=E (Kv4.2) and LQILGRYTLKASMRE (Shaker). The rate 
of inactivation of the Kv4.2/S4S5si, chimera was altered, which is 
consistent with the role of the S4-S5 loop in inactivation of Kv4 
channels. The effect of ETYA on both chimeras was intermediary 
between the insensitivity of Shaker (Fig. &1, right) and the potent 
inhibition of Kv4.2 (Fig. &1, left). This is illustrated in the cumu- 
lative dose response of Figure 8B. That the S4-S5 loop can confer 
sensitivity to the Shaker channel suggests the S4-S5 linker plays a 
role in fatty-acid inhibition. That exchange of this region in Kv4.2 
did not abolish sensitivity, however, indicates that this is not the 
only site of action. That the effect of ETYA on both chimeras is 
partial also indicates that other parts of the channel are necessary 
for the full response. 
Furthermore, if the S4-S5 loop were a binding site for fatty 
acids, an alteration might be expected in the IC,, values or in 
B 
100 r o Kv4.2 
l KV4.2/%S5Sh 
go _ v ShakedS4SSKd 
. Shaker 
-v--v 
I 
0 2 4 6 
U-Y.41 (JIM) 
Figure 8. The S4-S5 linker may influence the actions of fatty acids. A, A 
comparison (from left to right) of Kv4.2, chimera Kv4/S4S5,,, chimera 
ShakerlS4SS,,, and Shaker.The exchanged amino acids are i&ted in the 
text. The effect of 10 LLM ETYA (dotted traces and arrows) is comoared 
I I 
with control saline (sotid traces) for 90 msec steps to +40 mV. A nonin- 
activating (N-terminal-deleted) Shaker mutant was used in these experi- 
ments and revealed an additional action of ETYA on the Shaker channel, 
a decrease in current amplitude at the end of the pulse relative to peak 
amplitude. This effect is distinct from the inhibition of peak current in 
Kv4.2. Horizontal scale bar, 50 msec; vertical bar (from left to right), 1.1, 
1.0,4.5, and 2.4 yA. B, Cumulative dose-response curves for the reduction 
by ETYA of peak current amplitude evoked by steps to +40 mV. Each 
point is the average of at least five independent experiments. Bars indicate 
the SEM. 
the rank order of potencies of various fatty acids in the chi- 
mera. We examined the effect of several fatty acids (arachidon- 
ic acid, linoleic acid, and linolenyl alcohol) in the Kv4.2/S4S5si, 
chimera and found that, in comparison with their actions on 
Kv4.2, the cumulative dose-response curves for these com- 
pounds were reduced by a similar degree in the chimera, with 
no apparent change in the IC,,, values (data not shown). Thus, 
the involvement of the S4-S5 loop in fatty-acid action likely is 
indirect, and the binding site for these modulators likely resides 
elsewhere. 
DISCUSSION 
In this paper, we describe the inhibition by arachidonic acid of 
Kv4.2 channels expressed in Xenopus oocytes. Sensitivity to fatty 
acids appears to distinguish the members of the Kv4 family from 
all of the other cloned K+-channel genes that we screened in 
oocytes. The inhibition progressed under conditions in which the 
metabolism of arachidonic acid was likely to be prevented. A 
requirement for the participation of a kinase, a phosphatase, or 
Ca2+ also can be excluded because the inhibition took place in 
inside-out patches and was reversible. We have found no corre- 
lation between the potency of various fatty acids on Kv4.2 inhibi- 
tion and their expected influence on membrane fluidity. Taken 
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together, these observations are consistent with a model in which 
arachidonic acid interacts directly with the channel or a closely 
associated component and thereby reduces the amplitude of the 
current. 
Although in the oocytes only Kv4 family members showed a 
substantial inhibition by arachidonic acid, the situation in vivo 
may be more complex because of greater fatty-acid metabo- 
lism, the presence of other kinases and modifying enzymes, and 
the presence of additional channel subunits. Recently, for 
example, it has been shown that Kv1.5 channels expressed in 
Chinese hamster ovary cells are blocked by arachidonic acid 
(Honor6 et al., 1994). We and others (Timpe and Fantl, 1994) 
have observed only a very small reduction of that current in 
oocytes (see Fig. 1). The published modulation of Kv1.5 differs 
from the effect reported here for Kv4.2 in several respects. In 
Kv1.5, arachidonic acid caused a shift in the current-voltage 
relationship and a clear change in kinetics, such that more 
current was blocked at the end than at the beginning of a 
voltage step. In addition, it was reported that neither linoleic 
acid nor linolenic acid had any significant effect on Kv1.5 
(Honore et al., 1994). Moreover, the site of action in Kv1.5 
appears to be extracellular. In future experiments, these dif- 
ferences may be helpful in defining the structural requirements 
of modulation by fatty acids. Others (Gubitosi-Klug et al., 
1995) recently have described an action of arachidonic acid on 
the Kvl.1 channel expressed in Sf9 cells. This effect, which 
consists of modest changes in the activation and inactivation 
kinetics of Kvl.1, resembles some of the actions we have 
observed on other members of the Kvl family (Fig. 1). It is 
clearly distinct from the modulation of the Kv4-family channels 
that we have observed. 
Does the action of arachidonic acid on Kv4 channels ex- 
pressed in oocytes correspond to a modulation that occurs in 
vivo? As discussed below, there are several reported modula- 
tions of currents that are good candidates for in vivo correlates 
of this effect. However, one general issue for evaluating such a 
hypothesis concerns the levels of arachidonic acid effective in 
the present study and those that are reached in agonist- 
stimulated cells. Unfortunately, the latter are not known with 
certainty. It has been argued that the effects observed with 
concentrations of arachidonic acid in the low micromolar range 
have physiological significance (Anderson and Welsh, 1990), 
because the Km values of the enzymes that metabolize arachi- 
donic acid are 3-28 PM (Needleman et al., 1986). In addition, 
in cases in which the effect of a neurotransmitter has been 
demonstrated to be mediated by arachidonic acid, concentra- 
tions of 10 PM or greater were necessary to mimic the modu- 
lation (Piomelli et al., 1987; Kurachi et al., 1989b; Schweitzer et 
al., 1990). In the present study, a 69% inhibition of Kv4.2 
current was observed in inside-out patches at concentrations as 
low as 2 FM. Therefore, the physiological significance of the 
effect is highly plausible. 
All known members of the Kv4 family produce transient A-type 
currents, and even a subtle reduction of these currents by neuro- 
transmitters can produce substantial changes in the physiology of 
neuronal circuits (Harris-Warrick et al., 1994). In neurons and 
myocytes, there are abundant examples of A-current modulations 
that are candidates for a phenomenon corresponding to the one 
we see in oocytes. Neurotransmitter modulation of IA has been 
described in neostriatal (Akins et al., 1990) dorsal raphe (Agha- 
janian, 1985), sympathetic (Blair and Suprenant, 1993; Villarroel, 
1994) hippocampal (Nakajima et al., 1986; Saint et al., 1990), and 
cerebellar Purkinje neurons (Wang et al., 1992), as well as in 
cardiac myocytes (Apkon and Nerbonne, 1988) and Purkinje cells 
(Nakayama and Fozzard, 1988) (where it is designated I,,). The 
second messenger involved in the response is not known for any of 
these cells. 
Which of these effects are likely to represent fatty-acid 
inhibition of Kv4.2? Kv4.2 transcript and protein are present at 
relatively high levels in cardiac myocytes (Dixon and McKin- 
non, 1994; Barry et al., 1995) and it is likely, therefore, that 
Kv4.2 underlies much of I,, (Barry et al., 1995). Stimulation of 
01~ receptors inhibits I,,, and this inhibition leads to a prolon- 
gation of the action potential (Apkon and Nerbonne, 1988). 
Elsewhere, cyi receptors have been shown to mobilize arachi- 
donic acid (Burch et al., 1986) and, indeed, arachidonic acid 
can reduce I,, in cardiac myocytes (Damron et al., 1993). It is 
tempting, therefore, to propose that arachidonic acid is medi- 
ating at least part of the adrenergic modulation by interacting 
directly with a Kv4 channel. 
Similarly, in hippocampal neurons Kv4.2 is localized on the 
soma and dendrites (Sheng et al., 1992) and, therefore, likely 
contributes to I, in these cells. Muscarinic agonists reduce I, 
and thereby increase excitability (Nakajima et al., 1986). Mus- 
carinic responses also can include production of arachidonic 
acid (Conklin et al., 1988; Kanterman et al., 1990) and, thus, an 
arachidonic acid-mediated inhibition of Kv4.2 channels also 
may be at work in the hippocampus. Yet it should be noted that 
the correspondence is not perfect: the reduction of I, in 
hippocampal neurons is accompanied by a shift to more depo- 
larized potentials in the current-voltage relationship, indicat- 
ing that additional mechanisms may be taking place. The so- 
matostatin receptor that can be found in hippocampal neurons 
also can trigger the release of arachidonic acid (Bito et al., 
1993) and, therefore, it will be of interest to determine whether 
this peptide also can inhibit IA. 
In rat celiac ganglion neurons (Blair and Suprenant, 1993) 
and bullfrog sympathetic neurons (Villarroel, 1993, 1994) the 
inhibition of IA by muscarine is mimicked by arachidonic acid. 
These currents and their modulations are very similar to those 
reported here; therefore, although in sympathetic neurons the 
expression of Kv4 channels has not yet been demonstrated, 
inhibition by arachidonic acid of a channel in this family is also 
a distinct possibility. Thus, the present studies of expressed Kv4 
channels may provide insight into several modulatory phenom- 
ena in vivo and should encourage further investigation of the 
involvement of this signaling pathway in the regulation of 
transient currents. 
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